A Highly Durable RNAi Therapeutic Inhibitor of PCSK9

N Engl J Med. 2017 May 4;376(18):e38. doi: 10.1056/NEJMc1703361.
No abstract available

Publication types

  • Comment

MeSH terms

  • Cholesterol, LDL
  • Humans
  • Proprotein Convertases / genetics
  • RNA Interference*
  • RNAi Therapeutics*
  • Receptors, LDL / metabolism
  • Serine Endopeptidases / genetics

Substances

  • Cholesterol, LDL
  • Receptors, LDL
  • Proprotein Convertases
  • Serine Endopeptidases